This MedLibrary.org supplementary page on 2,5-dimethoxy-4-bromoamphetamine is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:
Related Sponsors
 |
This article needs additional citations for verification. Please help improve this article by adding reliable references. Unsourced material may be challenged and removed. (December 2007) |
| 2,5-Dimethoxy-4-bromoamphetamine | |
|---|---|
 |
|
 |
|
| IUPAC name | 1-(4-Bromo-2,5-dimethoxyphenyl)-2-aminopropane |
| Other names | 4-Bromo-2,5-dimethoxy-amphetamine |
| Identifiers | |
| CAS number | 32156-26-6 43061-15-0 43061-16-1 64638-07-9 |
| SMILES |
|
| Properties | |
| Molecular formula | C11H16BrNO2 |
| Molar mass | 274.15 g/mol |
| Melting point |
63-65 °C |
| Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) Infobox references |
|
DOB, also known as Brolamfetamine and Bromo-DMA, is a psychedelic hallucinogenic drug and a substituted amphetamine of the phenethylamine class of compounds, which can be used as an entheogen. DOB was first synthesized by Alexander Shulgin in 1967. In his book PiHKAL (Phenethylamines i Have Known And Loved), Shulgin lists the dosage range as 1 to 3mg for the racemate. The enantiopure compound dosage is at least half of that. DOB is generally taken orally. According to Shulgin, the effects of DOB typically last 18 to 30 hours. Onset of the drug is also long, sometimes taking up to three hours. The substance has been described as a more lucid, more amphetamine-like version of LSD, albeit far longer lasting.
Contents |
Chemistry
The full name of the chemical is 2,5-dimethoxy-4-bromoamphetamine. DOB has a stereocenter and R-(–)-DOB is the eutomer. This is an important finding as it is suggestive that it is targeting different receptors relative to most other phenethylamines (e.g. MDMA) where the R-isomer serves as the distomer. The toxicity of DOB is not fully known, although high doses may cause serious vasoconstriction of the extremities. DOB is one of the most potent compounds in PiHKAL; while the active dose is similar to that of DOI, another psychedelic amphetamine, DOB has been shown to have a higher efficacy in triggering downstream effects mediated by 5-HT2 receptors,1 making it likely to be slightly more dangerous than DOI in overdose, due to greater vasoconstrictive action. Omission of the amphetamine related α-methyl leads to 2C-B, a vastly safer compound that possesses a lower affinity for the 5-HT2A receptor and is a weaker receptor agonist.
(DOB) DOSAGE: 1.0 - 3.0 mg. DURATION: 18 - 30 h.
(DOI) DOSAGE: 1.5 - 4.0 mg. DURATION: 18 - 30 h.
(2C-B) DOSAGE: 12 - 25 mg. DURATION: 4 - 8 h.
(2C-I) DOSAGE: 14 - 25 mg. DURATION: 6 - 8 h.
There was a report of a death of a young lady following the snorting of an amount of DOB so massive, over nine milligrams of the drug was recovered from her body tissues in the post-mortem examination. It was said that she and her companion had thought that the drug they were using was MDA and, taking a dosage appropriate for this, effectively overdosed themselves. He survived, following convulsions and an extended period (several weeks) of being in a comatose state. Tragic examples have been reported that involve arterial vascular spasm. But in most overdose cases ascribed to DOB, the identity of the drug has remained unestablished.2
Misrepresentation as LSD
Sales of DOB on blotter paper, misrepresented as LSD, and in tablet form, misrepresented as MDMA or mescaline, have been frequently reported. Misrepresentation as LSD is extraordinarily dangerous, as DOB does not have the known safety profile of LSD: unlike LSD, DOB can have physically harmful (if not fatal) effects in overdose. The misrepresentation as LSD has been described by the periodical "High Times," helping some users to identify what they are actually taking. Since the mid 1980s, DOB has appeared on blotter paper and has been accidentally (or purposefully) sold as LSD. A common saying is,"If it's bitter, it's a spitter." Upon tasting the chemical, if one notices a highly bitter or "chemically" taste, this should serve as a warning sign that the drug is not LSD, but likely a psychedelic amphetamine (DOC, DOB or DOI) or some other chemical. An active dose of LSD (~100 μg) is so small that it has virtually no perceivable taste.
Legality
Internationally, DOB is a Schedule I drug under the Convention on Psychotropic Substances3.
References
- ^ Parrish JC, Braden MR, Gundy E & Nichols DE (2005). Differential phospholipase-C activation by phenylalkylamine serotonin 5-HT2A receptor agonists. J. Neurochem. 95: 1575-1584.
- ^ Erowid Online Books : "PiHKAL" - #62 DOB
- ^ "List of psychotropic substances under international control". Retrieved on 2007-03-30.
External links
|
|||||
Wikipedia content modification information:
- This page was last modified on 9 November 2008, at 18:43.
Wikipedia Authorship and Review
Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.
Wikipedia Usage Guidelines
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "2,5-dimethoxy-4-bromoamphetamine".
The URL for this specific entry is:
All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.